Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Leukemia, Myeloid, Chronic-Phase 6Neoplasm Metastasis 4Neoplasms 3Philadelphia Chromosome 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia 2Synovitis, Pigmented Villonodular 1Sarcoma 1Recurrence 1Peritoneal Neoplasms 1Neoplasm, Residual 1Melanoma 1Leukemia, Myeloid 1Hematologic Diseases 1Giant Cell Tumor of Tendon Sheath 1Genital Neoplasms, Female 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chordoma 1Cholangiocarcinoma 1Breast Neoplasms 1Blast Crisis 1Appendiceal Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Paclitaxel 8Hyperthermic Intraperitoneal Chemotherapy 6Mitomycin 5Cisplatin 5Fluorouracil 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Doxorubicin 3Cytoreduction Surgical Procedures 3Carboplatin 3Blood Specimen Collection 3sodium thiosulfate 2pembrolizumab 2Standard of Care 2Laparoscopy 2soluble LAG-3 protein, human 1relacorilant 1oregovomab 1olaparib 1nilotinib 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1avelumab 1X-Rays 1Topotecan 1Taxes 1Specimen Handling 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × nilotinib × 1 year × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡